10-KFiled 17 Nov 2026Industrials
Clearfield, Inc.CLFD
Annual report (10-K), FY2026
No notable change in AIR's read.
The nightly ledger
Every 8-K, 10-Q and 10-K that AIR's companies filed on SEC EDGAR, and what each one changed in AIR's read. Material filings first, newest first — never ordered by price. For 8-K filing alerts, follow a company and turn on filing emails.
By event type: Acquisitions · Major contracts
Last seven days · Material filings: 142 · All filings: 375
Tuesday 17 Nov75 filings read · 29 material
10-KFiled 17 Nov 2026Industrials
Clearfield, Inc.CLFD
Annual report (10-K), FY2026
No notable change in AIR's read.
10-KFiled 17 Nov 2026All industries
Annual report (10-K), FY2026
No notable change in AIR's read.
8-KFiled 17 Nov 2026All industries
Oklo Inc.OKLO
8-K · Item 1.01 — Material agreement
Oklo subsidiary entered into HALEU supply agreement with Centrus Energy for uranium enrichment services supporting Aurora powerhouse deployment. Oklo commits $35M in prepayments for enrichment services deliveries 2029–2031 on take-or-pay basis through 2039.
Progress is running ahead of attention.
Monday 16 Nov111 filings read · 39 material
10-KFiled 16 Nov 2026Biotech
Annual report (10-K), FY2026
The shares became cheaper on AIR's value read.
The price trend strengthened.
8-KFiled 16 Nov 2026Biotech
MapLight Therapeutics, Inc.MPLT
8-K · Item 1.01 — Material agreement
MapLight Therapeutics established a $100M at-the-market (ATM) offering agreement with Leerink Partners. The company may sell common stock over time at market prices with no obligation to do so. Agent commission capped at 3.0% of gross sales.
Market attention has faded.
Progress is running ahead of attention.
8-KFiled 16 Nov 2026All industries
8-K · Items 2.01, 3.03, 5.02 — Acquisition or disposal of assets
Black Hills Corporation completed its all-stock merger with NorthWestern Energy Group, effective November 13, 2026. The combined entity, renamed Bright Horizon Energy Corporation, issued ~60.2 million shares at 0.98 exchange ratio. Leadership and board restructured with integrated management team.
The filings read more positively.
Progress is running ahead of attention.
8-KFiled 16 Nov 2026All industries
CubeSmartCUBE
8-K · Item 2.02 — Results of operations
CubeSmart filed an 8-K furnishing a November 2026 investor presentation. The presentation contains corporate overview, historical milestones, governance practices, and strategic positioning. No new material business developments, financial results, or operational changes are disclosed.
No notable change in AIR's read.
10-KFiled 16 Nov 2026All industries
Annual report (10-K), FY2026
The reported numbers weakened.
8-KFiled 16 Nov 2026Banks
8-K · Item 1.01 — Material agreement
Hancock Whitney entered into a definitive merger agreement with Trustmark Corporation on November 11, 2026. Trustmark shareholders will receive 0.7463 HWC shares per Trustmark share. Five Trustmark directors will join HWC's board. Completion is subject to regulatory approvals and shareholder votes.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 16 Nov 2026Banks
Trustmark CorpTRMK
8-K · Item 1.01 — Material agreement
Trustmark Corporation entered into a definitive merger agreement with Hancock Whitney Corporation on November 11, 2026. Trustmark shareholders will receive 0.7463 Hancock Whitney shares per Trustmark share. Five Trustmark directors will join Hancock Whitney's board. Completion is subject to regulatory approvals and shareholder votes.
No notable change in AIR's read.
10-QFiled 16 Nov 2026Industrials
Evolution Metals & Technologies Corp.EMAT
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 16 Nov 2026Industrials
Energy Vault Holdings, Inc.NRGV
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became cheaper on AIR's value read.
The price trend weakened.
8-KFiled 16 Nov 2026Banks
8-K · Items 1.01, 2.03 — Material agreement
Enova's subsidiary RAOD amended its asset-backed securitization facility, extending the revolving period to November 2028 and maturity to November 2029. Total commitment is $365.1M across Class A and Class B loans at SOFR-based rates.
No notable change in AIR's read.
10-QFiled 16 Nov 2026Biotech
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
8-KFiled 16 Nov 2026Software / SaaS
8-K · Item 2.02 — Results of operations
No notable change in AIR's read.
10-QFiled 16 Nov 2026Biotech
Omeros CorpOMER
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 16 Nov 2026Biotech
MapLight Therapeutics, Inc.MPLT
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
Progress is running ahead of attention.
8-KFiled 16 Nov 2026All industries
Macerich CoMAC
8-K · Item 8.01 — Acquisition completed
Macerich acquired Oakridge Mall in San Jose for ~$250M. The deal is expected to be accretive to 2028 FFO by ~$0.02/share, reduce net debt/EBITDA by ~0.2x, and funded via partial settlement of forward equity from June 2026 offering.
Progress is running ahead of attention.
8-KFiled 16 Nov 2026All industries
AramarkARMK
8-K · Item 2.02 — Results of operations
Aramark delivered record fiscal 2026 results with 9% revenue growth, 16% operating income growth, and record free cash flow of $573M. Board authorized $1B share repurchase program and raised dividend 17%. FY2027 guidance projects 9-10% organic revenue growth and 15-19% AOI growth.
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 16 Nov 2026All industries
Idaho Strategic Resources, Inc.IDR
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
8-KFiled 16 Nov 2026All industries
Bally's CorpBALY
8-K · Item 2.02 — Results of operations
Q3 2026 consolidated revenue grew 21.7% YoY to $807.6M, driven by Intralot B2C (+22.8%) and North America Interactive (+25.6%). Casinos & Resorts grew 3.2%. Major projects on track: Chicago permanent casino spring 2027, Bronx project $400M financing closed.
No notable change in AIR's read.
10-QFiled 16 Nov 2026All industries
Bally's CorpBALY
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 16 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
8-KFiled 16 Nov 2026All industries
8-K · Item 2.02 — Results of operations
GXO announced 2030 financial targets (>7% organic revenue CAGR, >6.5% adjusted EBITA margin, 40-50% FCF conversion) and preliminary 2027 outlook (>5.5% organic revenue growth, >7.1% adjusted EBITDA margin) at Investor Day, reflecting management confidence in executing its strategy.
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 16 Nov 2026All industries
AecomACM
8-K · Items 2.02, 8.01 — Results of operations
AECOM reported FY2026 results with record backlog ($28.0B, +13%), record wins ($13.4B), and fourth-quarter margin records (18.2% operating, 19.2% EBITDA). Company raised quarterly dividend 10% to $0.34/share and issued FY2027 guidance for 4-6% NSR growth and record margins.
AIR measured this for the first time; no change to report.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 16 Nov 2026All industries
NorthWestern Energy Group, Inc.NWE
8-K · Items 2.01, 3.01, 3.03, 5.01, 5.02 — Acquisition or disposal of assets
NorthWestern Energy completed its merger with Black Hills Corporation on November 13, 2026, becoming a wholly owned subsidiary. NorthWestern shareholders received 0.98 Black Hills shares per share. NorthWestern delisted from Nasdaq; Black Hills renamed to Bright Horizon Energy and began trading under symbol HZN.
No notable change in AIR's read.
10-QFiled 16 Nov 2026Biotech
Oric Pharmaceuticals, Inc.ORIC
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
8-KFiled 16 Nov 2026All industries
8-K · Items 1.01, 2.03 — Material agreement
LAC increased Thacker Pass Phase 1 capex estimate from $2.93B to $3.83B (+$900M), driven by labor inflation, tariffs, logistics, and EPCM costs. Company will fund via $650M equity contribution and remaining DOE loan proceeds on 55.46:44.54 basis.
The filings read less positively.
8-KFiled 16 Nov 2026All industries
8-K · Items 2.02, 5.02 — Results of operations
Q3 2026 revenue grew 24% YoY to $147.9M; Adjusted EBITDA surged 614% to $4.9M. Company closed $20M in acquisition EBITDA YTD and has $20M+ under LOI. Secured $225M preferred equity and refinanced debt, reducing interest expense by ~$11.5M annually. Maintains 2026 guidance.
Progress is running ahead of attention.
10-QFiled 16 Nov 2026Software / SaaS
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
8-KFiled 16 Nov 2026Industrials
8-K · Item 2.02 — Results of operations
Powell Industries reported FY2026 results with 14% revenue growth to $1.3B, 22% net income increase to $221M ($6.04 EPS), and record $2.7B backlog (96% YoY growth). Q4 saw $710M new orders including two mega-orders ($250M LNG, $85M data center). Gross margin improved 190 bps to 31.3%.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 16 Nov 2026Industrials
8-K · Items 1.01, 2.03 — Material agreement
StandardAero secured $600M incremental term loan and initiated $350M accelerated share repurchase funded by new debt and cash. Company also announced plans to seek 18-month extension of revolving credit facility with up to $250M incremental commitments.
No notable change in AIR's read.
10-QFiled 16 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
8-KFiled 16 Nov 2026Biotech
Oric Pharmaceuticals, Inc.ORIC
8-K · Item 2.02 — Results of operations
ORIC initiated Himalayas-1 Phase 3 trial for rinzimetostat in mCRPC with Bayer partnership. Enozertinib showed 84% systemic and 70% CNS ORR in 1L EGFR atypical NSCLC. Cash position of $345M supports runway into 2H 2028.
Progress is running ahead of attention.
8-KFiled 16 Nov 2026Biotech
Omeros CorpOMER
8-K · Item 2.02 — Results of operations
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 16 Nov 2026Biotech
MapLight Therapeutics, Inc.MPLT
8-K · Item 2.02 — Results of operations
MapLight reported positive Phase 2 ZEPHYR results for ML-007C-MA in schizophrenia, met primary endpoint with statistically significant PANSS reduction. Planning Phase 3 ZEPHYR-2 trial with topline results expected H2 2027. VISTA trial in Alzheimer's disease psychosis ongoing; topline now expected 2028. Cash position of $463.4M funds operations through 2028.
Market attention has faded.
Progress is running ahead of attention.
8-KFiled 16 Nov 2026Biotech
Rezolute, Inc.RZLT
8-K · Item 1.01 — Material agreement
Rezolute completed pricing of ~$100M underwritten offering of common stock and pre-funded warrants, led by Frazier Life Sciences. Net proceeds (~$93.5M) will fund ersodetug commercialization preparation, working capital, and general corporate purposes.
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 16 Nov 2026Software / SaaS
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 16 Nov 2026Industrials
SS Innovations International, Inc.SSII
Quarterly report (10-Q), period ending 30 Sep 2026
The gap narrowed — attention is catching up.
8-KFiled 16 Nov 2026All industries
8-K · Item 2.02 — Results of operations
More of the market is starting to notice.
10-QFiled 16 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
8-KFiled 16 Nov 2026Biotech
8-K · Items 1.01, 8.01 — Material agreement
Vir Biotechnology announced and priced a public offering of 15 million shares at $10.00 per share, expected to raise ~$140.4 million net proceeds (or ~$161.5 million with full option exercise). Offering closes November 16, 2026.
No notable change in AIR's read.
Friday 20 Nov46 filings read · 20 material
8-KFiled 20 Nov 2026Industrials
Insulet CorpPODD
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 20 Nov 2026Industrials
Atmus Filtration Technologies Inc.ATMU
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 20 Nov 2026Banks
NB Bancorp, Inc.NBBK
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 20 Nov 2026All industries
News CorpNWSA
8-K · Item 8.01 — Other events
The shares became cheaper on AIR's value read.
8-KFiled 20 Nov 2026Biotech
Erasca, Inc.ERAS
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 20 Nov 2026Industrials
Itron, Inc.ITRI
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 20 Nov 2026Industrials
Phinia Inc.PHIN
8-K · Item 5.02 — Director or officer change
Market attention has faded.
The shares became cheaper on AIR's value read.
The price trend weakened.
8-KFiled 20 Nov 2026Banks
Chaince Digital Holdings Inc.CD
8-K · Item 8.01 — Other events
The filings read more positively.
Progress is running ahead of attention.
8-KFiled 20 Nov 2026All industries
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 20 Nov 2026Software / SaaS
Agilysys IncAGYS
Current report (8-K)
No notable change in AIR's read.
8-KFiled 20 Nov 2026All industries
8-K · Item 5.02 — Director or officer change
The shares became cheaper on AIR's value read.
The price trend weakened.
8-KFiled 20 Nov 2026Semiconductors
8-K · Item 2.05 — Exit or disposal costs
The shares became cheaper on AIR's value read.
8-KFiled 20 Nov 2026All industries
Southwest Gas Holdings, Inc.SWX
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 20 Nov 2026All industries
8-K · Item 5.02 — Director or officer change
The reported numbers weakened.
The shares became dearer on AIR's value read.
Attention caught up with the documented progress.
8-KFiled 20 Nov 2026All industries
Uniti Group Inc.UNIT
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 20 Nov 2026All industries
8-K · Item 8.01 — Other events
The reported numbers weakened.
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 20 Nov 2026All industries
American Airlines Group Inc.AAL
8-K · Item 5.02 — Director or officer change
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 20 Nov 2026Industrials
Adient plcADNT
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 20 Nov 2026All industries
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 20 Nov 2026All industries
Current report (8-K)
No notable change in AIR's read.
8-KFiled 20 Nov 2026All industries
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 20 Nov 2026Industrials
Proto Labs IncPRLB
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 20 Nov 2026All industries
Current report (8-K)
The gap narrowed — attention is catching up.
The price trend strengthened.
8-KFiled 20 Nov 2026All industries
Cracker Barrel Old Country Store, IncCBRL
Current report (8-K)
No notable change in AIR's read.
8-KFiled 20 Nov 2026Banks
Orange County Bancorp, Inc. /DE/OBT
8-K · Item 8.01 — Other events
The shares became cheaper on AIR's value read.
The price trend weakened.
8-KFiled 20 Nov 2026Software / SaaS
Intapp, Inc.INTA
Current report (8-K)
No notable change in AIR's read.
Thursday 19 Nov75 filings read · 29 material
8-KFiled 19 Nov 2026Industrials
Plexus CorpPLXS
8-K · Item 5.02 — Director or officer change
The reported numbers improved.
The shares became cheaper on AIR's value read.
The price trend weakened.
8-KFiled 19 Nov 2026Banks
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 19 Nov 2026Industrials
Plug Power IncPLUG
Current report (8-K)
No notable change in AIR's read.
8-KFiled 19 Nov 2026All industries
8-K · Item 8.01 — Other events
Market attention has faded.
The price trend weakened.
8-KFiled 19 Nov 2026All industries
8-K · Item 8.01 — Other events
The reported numbers weakened.
The shares became dearer on AIR's value read.
Attention caught up with the documented progress.
The price trend strengthened.
8-KFiled 19 Nov 2026All industries
HF Sinclair CorpDINO
8-K · Item 5.02 — Director or officer change
The shares became cheaper on AIR's value read.
The price trend weakened.
8-KFiled 19 Nov 2026All industries
Current report (8-K)
No notable change in AIR's read.
8-KFiled 19 Nov 2026All industries
Power Solutions International, Inc.PSIX
8-K · Item 5.02 — Director or officer change
The shares became cheaper on AIR's value read.
The price trend weakened.
8-KFiled 19 Nov 2026All industries
Lkq CorpLKQ
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 19 Nov 2026All industries
Current report (8-K)
No notable change in AIR's read.
8-KFiled 19 Nov 2026Banks
Metropolitan Bank Holding Corp.MCB
8-K · Item 5.02 — Director or officer change
The gap narrowed as the filings read less positively.
The price trend weakened.
8-KFiled 19 Nov 2026Software / SaaS
NIQ Global Intelligence plcNIQ
8-K · Item 5.02 — Director or officer change
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 19 Nov 2026All industries
Current report (8-K)
Market attention has faded.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 19 Nov 2026All industries
Current report (8-K)
No notable change in AIR's read.
8-KFiled 19 Nov 2026Biotech
Palvella Therapeutics, Inc.PVLA
8-K · Item 8.01 — Other events
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 19 Nov 2026Banks
Current report (8-K)
No notable change in AIR's read.
8-KFiled 19 Nov 2026All industries
Current report (8-K)
No notable change in AIR's read.
8-KFiled 19 Nov 2026All industries
Kbr, Inc.KBR
8-K · Item 5.02 — Director or officer change
The shares became cheaper on AIR's value read.
8-KFiled 19 Nov 2026Banks
8-K · Item 8.01 — Other events
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 19 Nov 2026All industries
Gevo, Inc.GEVO
Current report (8-K)
No notable change in AIR's read.
8-KFiled 19 Nov 2026Banks
National Bank Holdings CorpNBHC
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 19 Nov 2026All industries
8-K · Item 8.01 — Other events
Progress is running ahead of attention.
8-KFiled 19 Nov 2026Banks
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 19 Nov 2026All industries
Gates Industrial Corp Ltd.GTES
Current report (8-K)
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
8-KFiled 19 Nov 2026All industries
Alliancebernstein Holding L.P.AB
Current report (8-K)
No notable change in AIR's read.
8-KFiled 19 Nov 2026Banks
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 19 Nov 2026All industries
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 19 Nov 2026Banks
Amalgamated Financial Corp.AMAL
8-K · Item 5.02 — Director or officer change
The shares became cheaper on AIR's value read.
The price trend weakened.
8-KFiled 19 Nov 2026All industries
Forward Air CorpFWRD
8-K · Item 5.02 — Director or officer change
No notable change in AIR's read.
8-KFiled 19 Nov 2026Banks
Midland States Bancorp, Inc.MSBI
8-K · Item 8.01 — Other events
No notable change in AIR's read.
8-KFiled 19 Nov 2026Banks
8-K · Item 8.01 — Other events
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 19 Nov 2026Semiconductors
ALPHA & OMEGA SEMICONDUCTOR LtdAOSL
Current report (8-K)
The shares became cheaper on AIR's value read.
The price trend weakened.
Sun 22 Nov
CAPR · Capricor Therapeutics, Inc. · Regulatory date
As stated in the filing: “Deramiocel Biologics License Application (BLA) for Duchenne muscular dystrophy (DMD) under FDA review; PDUFA target action date of November 22, 2026 ●”
Announced by the company in 8-K on 10 Nov 2026
DYN · Dyne Therapeutics, Inc. · Regulatory date
As stated in the filing: “Capricor Therapeutics’ BLA for its cell therapy deramiocel is currently under FDA review with a PDUFA date of November 22, 2026.”
Announced by the company in 10-Q on 5 Nov 2026
SVRA · Savara Inc · Regulatory date
As stated in the filing: “The FDA determined that the Company’s responses to recent information requests by the Agency during its review constituted a major amendment to the BLA, resulting in a three-month extension of the Prescription Drug User Fee Act ("PDUFA") target action date to November 22, 2026.”
Announced by the company in 10-Q on 9 Nov 2026
Fri 27 Nov
BBIO · BridgeBio Pharma, Inc. · Regulatory date
As stated in the filing: “The first participant was dosed in ASCEND-ATTR, the Phase 3b/4 study to prospectively test disease reversal with Attruby - BBP-418 for LGMD2I/R9 has a November 27, 2026 PDUFA date, with Priority Review.”
Announced by the company in 8-K on 29 Oct 2026
Mon 30 Nov
COGT · Cogent Biosciences, Inc. · Regulatory date
As stated in the filing: “Potential FDA approval of bezuclastinib in GIST – PDUFA date of November 30, 2026 •”
Announced by the company in 8-K on 5 Nov 2026
JBIO · Jade Biosciences, Inc. · Regulatory date
As stated in the filing: “The FDA has also accepted a Biologics License Application for accelerated approval of povetacicept in IgAN, with a Prescription Drug User Fee Act target action date of November 30, 2026.”
Announced by the company in 10-Q on 13 Nov 2026
Wed 2 Dec
ARE · Alexandria Real Estate Equities, Inc. · Investor day
As stated in the filing: “We expect to introduce 2027 guidance and related assumptions at our Investor Day on December 2, 2026, consistent with our historical practice.”
Announced by the company in 8-K on 27 Apr 2026
Thu 3 Dec
EXEL · Exelixis, Inc. · Regulatory date
As stated in the filing: “In February 2026, we announced that the FDA had accepted our NDA and assigned a standard review, with a Prescription Drug User Fee Act (PDUFA) target action date of December 3, 2026.”
Announced by the company in 10-Q on 29 Oct 2026
Tue 8 Dec
GPC · Genuine Parts Co · Investor day
As stated in the filing: “In addition, the Company announced that both Global Automotive and Global Industrial will host separate investor days on December 8, 2026 and December 9, 2026, respectively.”
Announced by the company in 8-K on 9 Sep 2026
LGND · Ligand Pharmaceuticals Inc · Investor day
As stated in the filing: “Ligand will provide an updated 5-year outlook during the Company’s Investor Day on December 8, 2026.”
Announced by the company in 8-K on 14 Jul 2026
Wed 9 Dec
GPC · Genuine Parts Co · Investor day
As stated in the filing: “Investor Days GPC and Motion will host separate investor days in New York City, with GPC’s Investor Day scheduled for December 8, 2026, and Motion’s Investor Day scheduled for December 9, 2026.”
Announced by the company in 8-K on 9 Sep 2026
Sat 12 Dec
ANAB · Anaptysbio, Inc · Regulatory date
As stated in the filing: “FDA target action date (PDUFA) of December 12, 2026, for Quimilza in generalized pustular psoriasis (GPP) GSK and Tesaro Litigation Update •”
Announced by the company in 8-K on 12 Nov 2026
Thu 17 Dec
CORT · Corcept Therapeutics Inc · Regulatory date
As stated in the filing: “Relacorilant for patients with Cushing’s syndrome – Resubmitted New Drug Application Prescription Drug User Fee Act (PDUFA) date of December 17, 2026 “The ADA and EASD consensus statement is an important advance for the many patients whose difficult-to-control hyperglycemia is a manifestation of undiagnosed Cushing’s syndrome,” said Bill Guyer, PharmD, Corcept’s Chief Development Officer.”
Announced by the company in 8-K on 3 Nov 2026
Mon 23 Nov
MATW · Matthews International Corp · All industries
Annual results due — last year filed 21 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 30%, net income turned to a loss
AIR's current read: News flow Balanced, Gap Low · 0
Tue 24 Nov
BLBD · Blue Bird Corp · Industrials
Annual results due — last year filed 24 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 30%, net income up 408%
AIR's current read: News flow Balanced, Gap Very high · 82
PFLT · PennantPark Floating Rate Capital Ltd. · All industries
Annual results due — last year filed 24 Nov 2025
AIR's current read: News flow Balanced, Gap Very high · 71
Wed 25 Nov
AMTM · Amentum Holdings, Inc. · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2025, against a year earlier): revenue up 66%, net income turned positive
AIR's current read: News flow Balanced, Gap Low · 4
ARMK · Aramark · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2025, against a year earlier): revenue up 6%, net income up 23%
AIR's current read: News flow Balanced, Gap Medium · 10
CASH · Pathward Financial, Inc. · Banks
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 3%, net income down 31%
AIR's current read: News flow Balanced, Gap Low · 0
CLSK · Cleanspark, Inc. · Banks
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2024, against a year earlier): revenue up 129%, net loss widened
AIR's current read: News flow Balanced, Gap Very high · 54
GAP · Gap Inc · All industries
Quarterly results due — last year filed 25 Nov 2025
Last quarter (Q3 2024, against a year earlier): revenue down 7%, net income down 23%
AIR's current read: News flow Balanced, Gap Low · 3
ROAD · Construction Partners, Inc. · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 28%, net income up 35%
AIR's current read: News flow Balanced, Gap Low · 7
SJM · J M SMUCKER Co · All industries
Quarterly results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 7%, net loss widened
AIR's current read: News flow Balanced, Gap Low · 7
SMG · Scotts Miracle-Gro Co · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 1%, net income down 25%
AIR's current read: News flow Balanced, Gap Medium · 12
SMTC · Semtech Corp · Semiconductors
Quarterly results due — last year filed 25 Nov 2025
Last quarter (Q1 2027, against a year earlier): revenue up 16%, net income up 37%
AIR's current read: News flow Balanced, Gap Low · 0
TFSL · TFS Financial CORP · Banks
Annual results due — last year filed 25 Nov 2025
Last quarter (Q1 2019, against a year earlier): net income up 4%
AIR's current read: News flow Balanced, Gap Medium · 23
Fri 27 Nov
ATKR · Atkore Inc. · Industrials
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 8%, net income down 98%
AIR's current read: News flow Balanced, Gap Low · 0
BJ · BJ's Wholesale Club Holdings, Inc. · All industries
Quarterly results due — last year filed 26 Nov 2025
Last quarter (Q2 2027, against a year earlier): revenue up 16%, net income up 15%
AIR's current read: News flow Balanced, Gap Medium · 18
CENT · Central Garden & Pet Co · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 8%, net income down 5%
AIR's current read: News flow Balanced, Gap Low · 1
CFFN · Capitol Federal Financial, Inc. · Banks
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2020, against a year earlier): net income down 15%
AIR's current read: News flow Balanced, Gap Medium · 10
JJSF · J&J Snack Foods Corp · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 6%, net income down 20%
AIR's current read: News flow Balanced, Gap Low · 0
PD · PagerDuty, Inc. · Software / SaaS
Quarterly results due — last year filed 26 Nov 2025
Last quarter (Q1 2027, against a year earlier): revenue up 1%, net income turned positive
AIR's current read: News flow Balanced, Gap Low · 0
SPH · Suburban Propane Partners Lp · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue unchanged, net loss widened
AIR's current read: News flow Balanced, Gap Medium · 21
UTI · Universal Technical Institute Inc · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 7%, net income down 79%
AIR's current read: News flow Balanced, Gap Very high · 57
Mon 30 Nov
SNEX · StoneX Group Inc. · All industries
Annual results due — last year filed 28 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 15%, net income up 102%
AIR's current read: News flow Balanced, Gap Very high · 52
Tue 1 Dec
ESE · Esco Technologies Inc · Industrials
Annual results due — last year filed 1 Dec 2025
Last quarter (Q3 2026, against a year earlier): revenue up 14%, net income up 26%
AIR's current read: News flow Balanced, Gap Very high · 97
Wed 2 Dec
ASAN · Asana, Inc. · Software / SaaS
Quarterly results due — last year filed 2 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 10%, net loss narrowed
AIR's current read: News flow Balanced, Gap Low · 0
UNFI · United Natural Foods Inc · All industries
Quarterly results due — last year filed 2 Dec 2025
AIR's current read: News flow Balanced, Gap Low · 0
VSTS · Vestis Corp · All industries
Annual results due — last year filed 2 Dec 2025
Last quarter (Q3 2025, against a year earlier): revenue down 4%, net income turned to a loss
AIR's current read: News flow Balanced, Gap Low · 1
Thu 3 Dec
BOX · Box Inc · Software / SaaS
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 9%, net income up 43%
AIR's current read: News flow Balanced, Gap Low · 1
CRWD · CrowdStrike Holdings, Inc. · Software / SaaS
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue up 26%, net income turned positive
AIR's current read: News flow Balanced, Gap Low · 5
HQY · Healthequity, Inc. · All industries
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 8%, net income up 10%
AIR's current read: News flow Balanced, Gap Low · 0
KSS · KOHLS Corp · All industries
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q3 2024, against a year earlier): revenue down 5%, net income down 39%
AIR's current read: News flow Balanced, Gap Medium · 11
MEI · Methode Electronics Inc · Industrials
Quarterly results due — last year filed 3 Dec 2025
AIR's current read: News flow Balanced, Gap Low · 0
NCNO · nCino, Inc. · Software / SaaS
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue up 11%, net income up 145%
AIR's current read: News flow Balanced, Gap Low · 5
THO · Thor Industries Inc · Industrials
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q4 2026, against a year earlier): revenue down 8%, net income down 68%
AIR's current read: News flow Balanced, Gap Low · 4
Fri 4 Dec
AGX · Argan Inc · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 62%, net income up 51%
AIR's current read: News flow Balanced, Gap Low · 9
AMBA · Ambarella Inc · Semiconductors
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 13%, net loss narrowed
AIR's current read: News flow Balanced, Gap Low · 7
BF-B · Brown Forman Corp · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue down 1%, net income up 4%
AIR's current read: News flow Balanced, Gap Low · 0
CXM · Sprinklr, Inc. · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 1%, net income down 44%
AIR's current read: News flow Balanced, Gap Low · 9
DCI · DONALDSON Co INC · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q4 2026, against a year earlier): revenue up 8%, net income up 13%
AIR's current read: News flow Balanced, Gap Low · 9
FIVE · Five Below, Inc · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q3 2024, against a year earlier): revenue up 14%, net income down 10%
AIR's current read: News flow Balanced, Gap High · 27
GWRE · Guidewire Software, Inc. · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q3 2026, against a year earlier): revenue up 27%, net income down 64%
AIR's current read: News flow Balanced, Gap High · 44
NTNX · Nutanix, Inc. · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q3 2026, against a year earlier): revenue up 10%, net income up 14%
AIR's current read: News flow Balanced, Gap Medium · 22
REX · REX AMERICAN RESOURCES Corp · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 6%, net income up 336%
AIR's current read: News flow Balanced, Gap Low · 0
SAIC · Science Applications International Corp · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
AIR's current read: News flow Balanced, Gap High · 39
SWBI · Smith & Wesson Brands, Inc. · Industrials
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue up 32%, net income turned positive
AIR's current read: News flow Balanced, Gap Very high · 87
TITN · Titan Machinery Inc. · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue down 9%, net loss widened
AIR's current read: News flow Balanced, Gap Low · 0
Expected dates come from each company's filing history. They are not forecasts, and companies move them.
Sign in to follow companies
Follow a company and its filings show up here.
Sign inResearch, not tips. Filings come from SEC EDGAR; AIR's read is recomputed every trading day. A price move is shown as a fact beside a filing, never as the reason it is listed.